Skip to main content
. 2023 Oct 21;11:100529. doi: 10.1016/j.ejro.2023.100529

Fig. 1.

Fig. 1

Flowchart of selection criteria and study participation. csPCa – clinically significant prostate cancer; mpMRI – multiparametric magnetic resonance imaging.